Gilead Sciences, maker of the antiviral drug remdesivir, has come up with a price for the COVID-19 treatment that was less than some analysts expected.

An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.

(Image credit: ULRICH PERREY/POOL/AFP via Getty Images)



from Health : NPR https://ift.tt/2CQi6S9